Ritedose, South Carolina’s Leading Pharmaceutical Manufacturer, Buys 105 Acres of Land for Major Expansion.
50-percent growth in pharmaceutical manufacturing and sales spurs expansion, job creation
Ritedose Announces Launch of New Unit Dose Syringe Product: <em>Succinylcholine Chloride Injection 200 mg/10 mL (20 mg/mL)</em>
COLUMBIA, S.C. (March 25, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Succinylcholine Chloride Injection 200 mg/10 mL (20 mg/mL). It is the first of 12 Ritedose products expected to hit the market over the next six months for
Recent Comments